Rockwell Guides FY27 Organic Sales Up 6-9%, EPS $14.50-$15.50 on Data Center, Semi Demand

What happened

Rockwell Automation provided fiscal 2027 guidance during its Q4 FY2026 call, forecasting organic sales growth of 6% to 9% and adjusted EPS of $14.50 to $15.50, citing strong demand from data center, semiconductor, and manufacturing technology end markets. This represents a notable acceleration from the prior year's guidance and actuals, as the company's FY26 outlook had only called for 3-7% reported sales growth and adjusted EPS near $11.80 in the base case from our earlier analysis. The upbeat guidance follows a period of mixed signals; while the company's Q1 FY26 results showed strong product and software growth, its Lifecycle Services segment had declined 6% organically and unfulfilled performance obligations remained modest at $1.46 billion. Management is positioning the company to benefit from secular automation investment trends, but the guidance appears to lean heavily on continued capex in sectors like data centers and semiconductors, which may be cyclical and could face slowdowns if economic conditions deteriorate. The announcement shifts the narrative from a cautious 'sequential improvement' story to a more aggressive growth outlook, yet it remains to be seen whether the elevated earnings target is achievable without corresponding order backlog and services recovery.

Implication

The new FY27 guidance implies a significant earnings ramp, with the midpoint of $15.00 representing roughly a 27% increase over the base-case FY26 EPS of $11.80, which would require sustained double-digit growth and continued margin expansion. The market is likely to re-rate the stock upward if quarterly results confirm this trajectory, but the current valuation already embeds a high multiple at 45x trailing earnings, so any disappointment could lead to sharp downside. Key risks include the potential for data center and semiconductor capex to moderate, the need for Lifecycle Services to return to growth after a weak Q1, and the possibility that tariff-related pricing benefits reverse, compressing margins. Investors should monitor order intake, backlog, and RPO trends in upcoming quarters to verify that the demand is real and durable, rather than just management optimism. Until there is concrete evidence of demand-led growth across all segments, not just product sales, maintaining a WAIT rating (or considering a more conservative stance) remains prudent despite the upbeat guidance.

Thesis delta

The investment thesis shifts from waiting for confirmation of a moderate FY26 upcycle to assessing the credibility of a stronger FY27 growth commitment. The new guidance suggests that management expects a broadening demand recovery, but the lack of disclosed backlog improvement and ongoing Lifecycle Services weakness raise questions about whether the company can deliver. Consequently, the thesis moves from a cautious WAIT to a more demanding test: the company must now prove that its growth is demand-led and not reliant on temporary factors like tariff pricing or cyclical data center spending.